Hematology-Oncology Grand Rounds
Developing an S6K1-Targeting Strategy for PTEN-Deficient Cancer
David R. Plas, PhD
Department of Cancer Biology
University of Cincinnati
1. Review PTEN-S6K1 signal transduction.
2. Discuss the chemotherapeutic potential of S6K1 inhibitors in PTEN-deficient cancer.
3. Discuss TAM tyrosine kinase function and inhibition in cancer.
Become a Member